Medicine
Simbrinza 2 mg/10 mg per mL ophthalmic suspension
Simbrinza 2 mg/10 mg per mL ophthalmic suspension is a prescription medicine containing Brimonidine and Brinzolamide for ophthalmic use, marketed by Alcon Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store SIMBRINZA at 2°C to 25°C (36°F to 77°F).
Key facts
- Active ingredient (INN)
- Brimonidine and Brinzolamide
- Brand
- Simbrinza
- Strength
- 2 mg/10 mg per mL
- Dosage form
- Ophthalmic suspension
- Route
- Ophthalmic
- Packs
- 1 bottle
- Marketing authorisation holder
- Alcon Laboratories
- Manufacturer
- Alcon Laboratories
- Origin register
- US FDA, United States
- Storage
- Store SIMBRINZA at 2°C to 25°C (36°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EC54 Brimonidine and Brinzolamide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 May 2013
- Identifiers
- RxCUI 1421451, 1421456DailyMed set ID a49c157e-6310-0011-7b7f-e26fc1820d59NDC 0065-4147Application NDA204251
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, dropper in 1 carton / 8 mL in 1 bottle, dropper | 0065-4147-27 | Alcon Laboratories | 6 May 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Brimonidine and Brinzolamide is a fixed-dose combination of a carbonic anhydrase inhibitor and an alpha-adrenergic agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. MedsAcross supplies Brimonidine and Brinzolamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Brimonidine and BrinzolamideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SIMBRINZA prescribing information (Alcon Laboratories) · U.S. National Library of Medicine, DailyMed
- Simbrinza: European public assessment report (EPAR) · European Medicines Agency
Need Simbrinza 2 mg/10 mg per mL ophthalmic suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.